Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:CTXR
Tag: NASDAQ:CTXR
Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement...
Gavins Felicity
-
October 15, 2020
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Expands Its Intellectual Property Associated With Mino-Wrap...
Matt Wade
-
September 3, 2020
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At...
Kate Hudson
-
June 30, 2020
0
FDA Issues Positive Opinion On Citius Pharmaceuticals Inc.‘s (NASDAQ:CTXR) Proposed Mino-Lok...
Ward Sport
-
June 12, 2020
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Announce Expanded Access Protocol For IOTs Mino-Lok...
Gavins Felicity
-
June 4, 2020
0
1
2
Page 2 of 2
Recent Post
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...
Kate Hudson
-
May 1, 2024
0
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a prominent biopharmaceutical company focused on the development of innovative cancer therapies, recently witnessed significant stock price...
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
April 30, 2024
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
April 18, 2024
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
April 1, 2024
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...
March 29, 2024